Dr. Kiersten Stead is a Managing Partner at DCVC Bio. Prior to DCVC Bio, Dr. Stead was an Investment Director at Monsanto Growth Ventures (MGV) the Venture Capital arm of Monsanto, which was one of the most active investors globally in agriculture. Dr. Stead has over 15 years of experience in the Biotechnology space. Prior to joining MGV, Kiersten was on the Burrill & Company Venture Team which invested broadly in Life Sciences and Industrial Biotechnology.
Previously, Kiersten was a Management Consultant specialized in early stage company development. She was a Scientist in Genetics & Molecular Biology at the University of Alberta and at Agriculture and Agri-Food Canada. She holds a Ph.D. in Molecular Biology & Genetics. In addition, she also holds an MBA in Finance from the University of Alberta, where she attended as the AHFMR Scholar. Kiersten is a co-founder and Director of Pairwise, is on the Board of Atomwise, Farmlead, Plant Response Biotech, Vital Fields (acquired), Understory Weather (O) and Blue River Technology (acquired). She is also a member of the Investment Committee of Genome Canada GAAP, The Keystone Symposia Scientific Advisory Board, and the EULC, a sport-not-for-profit.